222 related articles for article (PubMed ID: 19179804)
1. Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: inhibitors of the Wnt/beta-catenin signaling pathway as novel anticancer drugs.
Takahashi-Yanaga F; Sasaguri T
J Pharmacol Sci; 2009 Feb; 109(2):179-83. PubMed ID: 19179804
[TBL] [Abstract][Full Text] [Related]
2. Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma.
Mori J; Takahashi-Yanaga F; Miwa Y; Watanabe Y; Hirata M; Morimoto S; Shirasuna K; Sasaguri T
Exp Cell Res; 2005 Nov; 310(2):426-33. PubMed ID: 16153639
[TBL] [Abstract][Full Text] [Related]
3. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
4. Differentiation-inducing factor-3 inhibits intestinal tumor growth in vitro and in vivo.
Kubokura N; Takahashi-Yanaga F; Arioka M; Yoshihara T; Igawa K; Tomooka K; Morimoto S; Nakatsu Y; Tsuzuki T; Nakabeppu Y; Matsumoto T; Kitazono T; Sasaguri T
J Pharmacol Sci; 2015 Apr; 127(4):446-55. PubMed ID: 25913757
[TBL] [Abstract][Full Text] [Related]
5. Acceleration of bone development and regeneration through the Wnt/β-catenin signaling pathway in mice heterozygously deficient for GSK-3β.
Arioka M; Takahashi-Yanaga F; Sasaki M; Yoshihara T; Morimoto S; Takashima A; Mori Y; Sasaguri T
Biochem Biophys Res Commun; 2013 Nov; 440(4):677-82. PubMed ID: 24099767
[TBL] [Abstract][Full Text] [Related]
6. Differentiation-inducing factor-1 suppresses the expression of c-Myc in the human cancer cell lines.
Jingushi K; Nakamura T; Takahashi-Yanaga F; Matsuzaki E; Watanabe Y; Yoshihara T; Morimoto S; Sasaguri T
J Pharmacol Sci; 2013; 121(2):103-9. PubMed ID: 23357875
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor effects of differentiation-inducing factor-1 in malignant melanoma: GSK-3-mediated inhibition of cell proliferation and GSK-3-independent suppression of cell migration and invasion.
Arioka M; Takahashi-Yanaga F; Kubo M; Igawa K; Tomooka K; Sasaguri T
Biochem Pharmacol; 2017 Aug; 138():31-48. PubMed ID: 28501501
[TBL] [Abstract][Full Text] [Related]
8. Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3beta and degrades cyclin D1 in mammalian cells.
Takahashi-Yanaga F; Taba Y; Miwa Y; Kubohara Y; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
J Biol Chem; 2003 Mar; 278(11):9663-70. PubMed ID: 12522140
[TBL] [Abstract][Full Text] [Related]
9. Ajuba negatively regulates the Wnt signaling pathway by promoting GSK-3beta-mediated phosphorylation of beta-catenin.
Haraguchi K; Ohsugi M; Abe Y; Semba K; Akiyama T; Yamamoto T
Oncogene; 2008 Jan; 27(3):274-84. PubMed ID: 17621269
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design of benzo[e]isoindole-1,3-dione derivatives as selective GSK-3β inhibitors to activate Wnt/β-catenin pathway.
Yue H; Lu F; Shen C; Quan JM
Bioorg Chem; 2015 Aug; 61():21-7. PubMed ID: 26057861
[TBL] [Abstract][Full Text] [Related]
11. Polycyclic aromatic hydrocarbons and dibutyl phthalate disrupt dorsal-ventral axis determination via the Wnt/β-catenin signaling pathway in zebrafish embryos.
Fairbairn EA; Bonthius J; Cherr GN
Aquat Toxicol; 2012 Nov; 124-125():188-96. PubMed ID: 22975441
[TBL] [Abstract][Full Text] [Related]
12. Curcumin activates Wnt/β-catenin signaling pathway through inhibiting the activity of GSK-3β in APPswe transfected SY5Y cells.
Zhang X; Yin WK; Shi XD; Li Y
Eur J Pharm Sci; 2011 Apr; 42(5):540-6. PubMed ID: 21352912
[TBL] [Abstract][Full Text] [Related]
13. GSK-3β suppresses the proliferation of rat hepatic oval cells through modulating Wnt/β-catenin signaling pathway.
Ji XK; Xie YK; Zhong JQ; Xu QG; Zeng QQ; Wang Y; Zhang QY; Shan YF
Acta Pharmacol Sin; 2015 Mar; 36(3):334-42. PubMed ID: 25661318
[TBL] [Abstract][Full Text] [Related]
14. Lithium stimulates human bone marrow derived mesenchymal stem cell proliferation through GSK-3β-dependent β-catenin/Wnt pathway activation.
Zhu Z; Yin J; Guan J; Hu B; Niu X; Jin D; Wang Y; Zhang C
FEBS J; 2014 Dec; 281(23):5371-89. PubMed ID: 25265417
[TBL] [Abstract][Full Text] [Related]
15. DIF-1 inhibits tumor growth in vivo reducing phosphorylation of GSK-3β and expressions of cyclin D1 and TCF7L2 in cancer model mice.
Takahashi-Yanaga F; Yoshihara T; Jingushi K; Igawa K; Tomooka K; Watanabe Y; Morimoto S; Nakatsu Y; Tsuzuki T; Nakabeppu Y; Sasaguri T
Biochem Pharmacol; 2014 Jun; 89(3):340-8. PubMed ID: 24670930
[TBL] [Abstract][Full Text] [Related]
16. The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer.
Zhang J; Gill AJ; Issacs JD; Atmore B; Johns A; Delbridge LW; Lai R; McMullen TP
Hum Pathol; 2012 Jul; 43(7):1044-50. PubMed ID: 22204713
[TBL] [Abstract][Full Text] [Related]
17. 3-methoxyapigenin modulates β-catenin stability and inhibits Wnt/β-catenin signaling in Jurkat leukemic cells.
Chuang KA; Lieu CH; Tsai WJ; Huang WH; Lee AR; Kuo YC
Life Sci; 2013 Apr; 92(12):677-86. PubMed ID: 23333831
[TBL] [Abstract][Full Text] [Related]
18. Octreotide stimulates somatostatin receptor-induced apoptosis of SW480 colon cancer cells by activation of glycogen synthase kinase-3β, A Wnt/β-catenin pathway modulator.
Wang S; Bao Z; Liang QM; Long JW; Xiao ZS; Jiang ZJ; Liu B; Yang J; Long ZX
Hepatogastroenterology; 2013 Oct; 60(127):1639-46. PubMed ID: 24634935
[TBL] [Abstract][Full Text] [Related]
19. The Wnt/β-catenin signaling in endometriosis, the expression of total and active forms of β-catenin, total and inactive forms of glycogen synthase kinase-3β, WNT7a and DICKKOPF-1.
Pazhohan A; Amidi F; Akbari-Asbagh F; Seyedrezazadeh E; Farzadi L; Khodarahmin M; Mehdinejadiani S; Sobhani A
Eur J Obstet Gynecol Reprod Biol; 2018 Jan; 220():1-5. PubMed ID: 29107840
[TBL] [Abstract][Full Text] [Related]
20. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
Lu WJ; Chua MS; Wei W; So SK
Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
